Polymyalgia Rheumatica Clinical Trials (Enrolling Now)



Study Details:

A 52-week double-blind research study evaluating the efficacy and safety of an investigational product called ABBV-154 administered in a subcutaneous injection every other week.

This study may be an option for you if you:

  • You are taking glucocorticoids and still experiencing PMR symptoms
  • Have previously failed treatment with a TNF antagonist (adalimumab, etanercept, infliximab, certolizumab, golimumab).

Other criteria apply. Please discuss with a staff member to see if this study is
a good fit for you. Qualified participants will receive all study-related care and
study medication or placebo at no cost.

Participant Compensation:

Financial compensation may be provided for time commitment and travel

Application for Current Clinical Research Study

"*" indicates required fields

Best Method of Contact*
Best Time of Day to Contact*
Study You Are Interested In*
This field is for validation purposes and should be left unchanged.

Scroll to Top